Gabapentin for acute pain in sickle cell disease: A randomized double‐blinded placebo‐controlled phase II clinical trial

Pain in sickle cell disease (SCD) can have a neuropathic component. This randomized phase II double‐blinded placebo‐controlled study evaluated the efficacy of gabapentin in reducing pain and opioid consumption (morphine‐equivalent dose [MED]) during acute vaso‐occlusive crisis (VOC). Of 90 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Puri, Latika, Nottage, Kerri, Hankins, Jane S., Wang, Winfred C., McGregor, Olivia, Gossett, Jeffrey M., Kang, Guolian, Anghelescu, Doralina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Sickle Cell, Thrombosis, and Haematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175868/
https://www.ncbi.nlm.nih.gov/pubmed/35844692
http://dx.doi.org/10.1002/jha2.188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175868/
https://www.ncbi.nlm.nih.gov/pubmed/35844692
http://dx.doi.org/10.1002/jha2.188

Ejemplares similares